41.10 USD
↗ 1.85 (4.71%)AT CLOSE (03:59 PM EDT)
Teva Pharmaceutical Industries Limited
TEVANYSE • USD
41.36
↗ 0.26 (0.64%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
41.36
↗ 0.26 (0.64%)
Market: CLOSED
Teva Pharmaceutical Industries Limited (TEVA) is currently trading at $41.10. The technical outlook is "Strong Buy" and the fundamental picture shows "Neutral". Key drivers include a concerning Altman Z-Score in the distress zone, a bullish Golden Cross on the moving averages and bullish moving average alignment. TEVA is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Oct 9, 2026.
Open?$40.22
High?$42.02
Low?$40.12
Prev. Close?$39.25
Volume?14.8M
Avg. Volume?5.5M
VWAP?$41.30
Rel. Volume?2.71x
Bid / Ask
Bid?$41.18 × 300
Ask?$41.55 × 100
Spread?$0.37
Midpoint?$41.36
Valuation & Ratios
Market Cap?47.9B
Shares Out?N/A
Float?1.2B
Float %?99.6%
P/E Ratio?67.80
P/B Ratio?6.18
EPS?$0.61
Dividend?0.00%
Ex-Dividend?N/A
RelatedABBV
News
Profile
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Employees
32.8K
Market Cap
45.8B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1982-02-16
Address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
TEL AVIV,
Phone: 972 (3) 914-8213
TEL AVIV,
Phone: 972 (3) 914-8213
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?10
Momentum?69
Short Sent.?55
Piotroski F-Score?4/9Mixed
Altman Z-Score?0.93Distress
Confidence?66%Moderate
Short InterestHigh
Short % of Float?2.57%Low
Short Interest?29.8M
Days to Cover?5.4
Free Float1.2B
Avg Daily Volume5.5M
Settlement Date2026-09-30
Financial Health
Current Ratio?0.90Weak
Quick Ratio?0.69Weak
Cash Ratio?0.24Low
Debt/Equity?2.14High
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score61/100
P/E?67.8PRICEY▾
Peers100
S&P7
P/B?6.18FAIR▾
S&P30
P/S?2.77CHEAP▾
Peers100
S&P54
P/FCF?35.6PRICEY▾
Peers50
S&P21
EV/EBITDA?14.3FAIR▾
Peers100
S&P54
EV/Sales?3.52FAIR▾
Peers100
S&P53
Returns & Efficiency
ROE?9.1%FAIR▾
S&P31
ROA?1.8%WEAK▾
Peers50
S&P18
Cash Flow & Enterprise
FCF?$1.3B
Enterprise Value?$60.9B
Fundamentals ratios updated end of day